To understand whether the recognition of p53 mutants by the TILs is a common phenomenon across different cancer types, TILs from 28 patients with several types of cancers were screened by autologous antigen-presenting cells that present corresponding p53 mutant peptides by electroporated with tandem minigenes or pulsed with peptides. This evidence concerns the gene TP53 and cancer.